February 4, 2020
Study finds blood test accurately tracks HPV-linked head and neck cancer
An experimental blood test accurately detected HPV-linked head and neck cancer recurrence and confirmed when patients remained cancer-free.
Category: News from Lineberger
February 3, 2020
Researchers develop method to engineer immune cells so they grow even in hostile tumors
Tumors can create a hostile environment for cancer-fighting immune cells. In a new study, University of North Carolina Lineberger Comprehensive Cancer Center researchers have developed a method for engineering immune cells to improve their survival and proliferation, even within a hostile tumor. Researchers led by UNC Lineberger’s Gianpietro Dotti, MD, report in the journal Nature …
February 3, 2020
Silverstein celebrates five years as a ‘previvor’ with UNC Lineberger fundraiser
Cancer genetic testing revealed that Beth Silverstein was at high risk for breast and ovarian cancer. She took charge of her destiny and took preventive steps through surgery, and now celebrates five years as a "previvor" with a fundraiser for UNC Lineberger.
January 30, 2020
UNC Lineberger discovery would allow researchers to fine-tune activity of cancer-hunting immune cells
A discovery by University of North Carolina Lineberger Comprehensive Cancer Center researchers could allow scientists to fine-tune genetically engineered immune cells to heighten their killing power against tumors or to decrease their activity level in the case of severe side effects. In a study published in Cancer Cell, researchers led by UNC Lineberger’s Gianpietro Dotti, …
January 16, 2020
Teaming up in the lab and in life: researchers make an impact on cancer science
Yuliya Pylayeva-Gupta, PhD, and Gaorav Gupta, MD, PhD, use their natural curiosity and drive to tackle cancer through their research at UNC Lineberger.
January 16, 2020
Comparing cancer costs is challenging, despite new price transparency rules
Comparison shopping for airfare, a TV, or a car can be straightforward online. The same cannot be said for checking what hospitals charge for a standard radiation treatment for prostate cancer, according to a report published in JAMA Oncology. Trevor Royce, MD, MPH, MS, of the University of North Carolina Lineberger Comprehensive Cancer Center, is …
January 14, 2020
Ray receives Young Investigator Award to support breast cancer research
The Conquer Cancer Foundation of the American Society of Clinical Oncology, in conjunction with the Breast Cancer Research Foundation, has presented a Young Investigator Award to UNC Lineberger’s Emily Ray, MD, MPH. Ray, who is an assistant professor of medicine in the division of hematology/oncology at UNC School of Medicine, will use the one year, …
January 14, 2020
Dittus and colleagues write the book on rare lymphomas
UNC Lineberger’s Christopher Dittus, DO, MPH, assistant professor of medicine at UNC School of Medicine, is the editor of a new book that provides a comprehensive review of how to diagnose and manage rare lymphomas, with a focus on novel treatment approaches. UNC Lineberger faculty and trainees contributed chapters to the volume. “Novel Therapeutics for …
January 14, 2020
Phase I study indicates drug could boost immune function in blood cancers
An early-stage clinical study investigating a method of boosting the body’s defenses against two blood cancers found the drug pomalidomide could be safely added to conventional treatments, and help improve immune function. University of North Carolina Lineberger Comprehensive Cancer Center researcher Joshua Zeidner, MD, assistant professor in the UNC School of Medicine Division of Hematology/Oncology, …
January 13, 2020
Researchers find clues to drug resistance in medulloblastoma subtype
A study led by UNC Lineberger's Tim Gershon, MD, PhD, shows new evidence to explain how drug resistance develops in a major subtype of medulloblastoma.